Newsroom

Press Releases

Saniona Icon blue
April 12, 2021
PRESS RELEASE April 12, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First
March 17, 2021
Financial highlights Jan - Dec 2020 (Jan - Dec 2019 restated) Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67) Q4 2020 (Q4 2019 restated) Revenue was
Displaying 31 - 40 of 41